The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Gut Microbe-Generated Trimethylamine N -Oxide From Dietary Choline Is Prothrombotic in Subjects
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TMAO has been shown to directly interact with platelets (human and murine), increasing their responsiveness, and promoting a prothrombotic phenotype.4,5”
From Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women (2019) · cites this paper as [5]
In the citing paper
“recent human observational and interventional studies show that TMAO levels can increase substantially (>10 lM) with chronic supplementation.4,5”
From Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women (2019) · cites this paper as [5]
In the citing paper
“In a subsequent human feeding study, healthy volunteers (both omnivore and vegan/vegetarian) that were orally supplemented with choline exhibited higher levels of TMAO and concomitant enhanced platelet responsiveness and aggregation77, 118.”
From Gut microbiota and cardiovascular disease. (2020) · cites this paper as [118]
In the citing paper
“The TMAO pathway is an excellent example of this, given the nutrient precursors are more abundant in a Western diet, and diets rich in phosphatidylcholine and carnitine are associated with heightened levels of TMAO, whereas vegetarian or vegan diets have reduced nutrient precursors111, 118.”
From Gut microbiota and cardiovascular disease. (2020) · cites this paper as [118]
In the citing paper
“It was observed that although blood lipid levels in the mice remained similar between all diet groups, TMAO was significantly elevated in the fish protein group.”
From Dietary metabolism, the gut microbiome, and heart failure (2019) · cites this paper as [166]
In the citing paper
“a recent study supplementing fish protein to a western diet in Apolipoprotein E−/− mice showed increases in atherosclerotic plaque area and calcification when compared to the matched soy or casein protein fed counterparts166.”
From Dietary metabolism, the gut microbiome, and heart failure (2019) · cites this paper as [166]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
Self-citationIntestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
Koeth, R. A., Wang, Z., Levison, B. S., Buffa, J. A., Org, E., Sheehy, B. T., Britt, E. B., Fu, X., Wu, Y., Li, L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3145 · Cited by 4,386
Self-citationIntestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
Tang, W. H. W., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., Wu, Y., & Hazen, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109400 · Cited by 3,400
Self-citationGut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
Zhu, W., Gregory, J. C., Org, E., Buffa, J. A., Gupta, N., Wang, Z., Li, L., Fu, X., Wu, Y., Mehrabian, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.011 · Cited by 1,968
Self-citationThe influence of non-steroidal anti-inflammatory drugs on the gut microbiome
Rogers, M. A. M., & Aronoff, D. M. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.10.003 · Cited by 346
Flagged first, then by citations
Cited by
Sorted by citations
Gut microbiota and cardiovascular disease.
Witkowski, M., Weeks, T. L., & Hazen, S. L. (2020) · Circulation Research · doi:10.1161/circresaha.120.316242 · Cited by 1,051
Self-citationDietary metabolism, the gut microbiome, and heart failure
Tang, W. H. W., Li, D. Y., & Hazen, S. L. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0108-7 · Cited by 789
Self-citationRole of gut microbiota-generated short-chain fatty acids in metabolic and cardiovascular health
Chambers, E. S., Preston, T., Frost, G., & Morrison, D. J. (2018) · Current Nutrition Reports · doi:10.1007/s13668-018-0248-8 · Cited by 691
Development of a gut microbe–targeted nonlethal therapeutic to inhibit thrombosis potential
Roberts, A. B., Gu, X., Buffa, J. A., Hurd, A. G., Wang, Z., Zhu, W., Gupta, N., Skye, S. M., Cody, D. B., Levison, B. S., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0128-1 · Cited by 552
Self-citationIntestinal Microbiota in Cardiovascular Health and Disease
Tang, W. H. W., Bäckhed, F., Landmesser, U., & Hazen, S. L. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.024 · Cited by 524
Self-citationWang, Z., Bergeron, N., Levison, B. S., Li, X. S., Chiu, S., Jia, X., Koeth, R. A., Li, L., Wu, Y., Tang, W. H. W., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy799 · Cited by 496
Self-citationGut microbiota derived metabolites in cardiovascular health and disease
Wang, Z., & Zhao, Y. (2018) · Protein & Cell · doi:10.1007/s13238-018-0549-0 · Cited by 491
Self-citationMicrobial modulation of cardiovascular disease
Brown, J. M., & Hazen, S. L. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.149 · Cited by 440
Self-citationThe progress of gut microbiome research related to brain disorders
Zhu, S., Jiang, Y., Xu, K., Cui, M., Ye, W., Zhao, G., Jin, L., & Chen, X. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-1705-z · Cited by 419
Precision Nutrition and the Microbiome, Part I: Current State of the Science
Mills, S., Stanton, C., Lane, J. A., Smith, G., & Ross, R. P. (2019) · Nutrients · doi:10.3390/nu11040923 · Cited by 426
The Role of the Gut Microbiota in the Relationship Between Diet and Human Health
Perler, B. K., Friedman, E. S., & Wu, G. D. (2022) · Annual Review of Physiology · doi:10.1146/annurev-physiol-031522-092054 · Cited by 402
Yang, S., Li, X., Yang, F., Zhao, R., Pan, X., Liang, J., Tian, L., Li, X., Liu, L., Xing, Y., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01360 · Cited by 360
l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans
Koeth, R. A., Lam-Galvez, B. R., Kirsop, J., Wang, Z., Levison, B. S., Gu, X., Copeland, M. F., Bartlett, D., Cody, D. B., Dai, H. J., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci94601 · Cited by 327
Self-citationTMAO: how gut microbiota contributes to heart failure
Zhang, Y., Wang, Y., Ke, B., & Du, J. (2020) · Translational research · doi:10.1016/j.trsl.2020.08.007 · Cited by 311
The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation
Rahman, M. M., Islam, F., Harun-Or-Rashid, M., Mamun, A. A., Rahaman, M. S., Islam, M. M., Meem, A. F. K., Sutradhar, P. R., Mitra, S., Mimi, A. A., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.903570 · Cited by 272
Metabolic retroconversion of trimethylamine N-oxide and the gut microbiota
Hoyles, L., Jiménez-Pranteda, M. L., Chilloux, J., Brial, F., Myridakis, A., Aranias, T., Magnan, C., Gibson, G. R., Sanderson, J. D., Nicholson, J. K., et al. (2018) · Microbiome · doi:10.1186/s40168-018-0461-0 · Cited by 260
Multi-omics signatures of the human early life exposome
Maître, L., Bustamante, M., Hernandéz-Ferrer, C., Thiel, D., Lau, C. E., Siskos, A., Vives-Usano, M., Ruiz-Arenas, C., Pelegrí-Sisó, D., Robinson, O., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34422-2 · Cited by 242
The Role of Gut Microbiota in Atherosclerosis and Hypertension
Ma, J., & Li, H. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01082 · Cited by 234
Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease?
Canyelles, M., Borràs, C., Rotllán, N., Tondo, M., Escolá‐Gil, J. C., & Blanco‐Vaca, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031940 · Cited by 218
Gut microbiota in atherosclerosis: focus on trimethylamine N‐oxide
Zhu, Y., Li, Q., & Jiang, H. (2020) · Apmis · doi:10.1111/apm.13038 · Cited by 210
Lyu, M., Wang, Y., Fan, G., Wang, X., Xu, S.-Y., & Zhu, Y. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02146 · Cited by 197
The gut microbiota and its interactions with cardiovascular disease
Xu, H., Wang, X., Feng, W., Liu, Q., Zhou, S., Liu, Q., & Cai, L. (2020) · Microbial Biotechnology · doi:10.1111/1751-7915.13524 · Cited by 196
Skye, S. M., Zhu, W., Romano, K. A., Guo, C.-J., Wang, Z., Jia, X., Kirsop, J., Haag, B., Lang, J. M., DiDonato, J. A., et al. (2018) · Circulation Research · doi:10.1161/circresaha.118.313142 · Cited by 189
Self-citationGut microbiome and its role in cardiovascular diseases
Ahmadmehrabi, S., & Tang, W. H. W. (2017) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000445 · Cited by 191
Self-citationGupta, N., Buffa, J. A., Roberts, A. B., Sangwan, N., Skye, S. M., Li, L., Ho, K. J., Varga, J., DiDonato, J. A., Tang, W. H. W., et al. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.314139 · Cited by 187
Self-citationGut Microbiota and Ischemic Stroke: The Role of Trimethylamine N-Oxide
Nam, H. S. (2019) · Journal of Stroke · doi:10.5853/jos.2019.00472 · Cited by 176
Microbial Contribution to the Human Metabolome: Implications for Health and Disease
Treuren, W. V., & Dodd, D. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-043559 · Cited by 180
Gut microbes impact stroke severity via the trimethylamine N-oxide pathway
Zhu, W., Romano, K. A., Li, L., Buffa, J. A., Sangwan, N., Prakash, P., Tittle, A. N., Li, X. S., Fu, X., Androjna, C., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.05.002 · Cited by 167
Self-citationZhu, W., Buffa, J. A., Wang, Z., Warrier, M., Schugar, R., Shih, D. M., Gupta, N., Gregory, J. C., Org, E., Fu, X., et al. (2018) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14234 · Cited by 161
Self-citationA Multi-omic Association Study of Trimethylamine N-Oxide
Manor, O., Zubair, N., Conomos, M. P., Xu, X., Rohwer, J. E., Krafft, C. E., Lovejoy, J. C., & Magis, A. T. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.096 · Cited by 165
The gut microbiome and elevated cardiovascular risk in obesity and autoimmunity
Kasselman, L. J., Vernice, N. A., DeLeon, J. R., & Reiss, A. B. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.02.036 · Cited by 162
Long-Term Changes in Gut Microbial Metabolite Trimethylamine N-Oxide and Coronary Heart Disease Risk
Heianza, Y., Ma, W., DiDonato, J. A., Sun, Q., Rimm, E. B., Hu, F. B., Rexrode, K. M., Manson, J. E., & Qi, L. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.11.060 · Cited by 161
Wu, W., Chen, C., Liu, P., Panyod, S., Liao, B., Chen, P.-C., Kao, H., Kuo, H., Kuo, C., Chiu, T. H. T., et al. (2018) · Gut · doi:10.1136/gutjnl-2018-317155 · Cited by 156
The gut microbiome and cardiovascular disease: current knowledge and clinical potential
Ahmad, A. F., Dwivedi, G., O’Gara, F., Caparros-Martin, J. A., & Ward, N. C. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00376.2019 · Cited by 165
Li, X., Su, C., Jiang, Z., Yang, Y., Zhang, Y., Yang, M., Zhang, X., Du, Y., Zhang, J., Wang, L., et al. (2021) · npj Biofilms and Microbiomes · doi:10.1038/s41522-021-00205-8 · Cited by 155
Nemet, I., Li, X. S., Haghikia, A., Li, L., Wilcox, J. D., Romano, K. A., Buffa, J. A., Witkowski, M., Demuth, I., König, M., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad333 · Cited by 131
Self-citationOrgan, C. L., Li, Z., Sharp, T. E., Polhemus, D. J., Gupta, N., Goodchild, T. T., Tang, W. H. W., Hazen, S. L., & Lefer, D. J. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.016223 · Cited by 128
Self-citationBrown, S.-A. N., & Pereira, N. L. (2018) · Journal of Personalized Medicine · doi:10.3390/jpm8010008 · Cited by 124
TMAO as a biomarker of cardiovascular events: a systematic review and meta-analysis
Guasti, L., Galliazzo, S., Molaro, M., Visconti, E., Pennella, B., Gaudio, G. V., Lupi, A., Grandi, A. M., & Squizzato, A. (2020) · Internal and Emergency Medicine · doi:10.1007/s11739-020-02470-5 · Cited by 129
Witkowski, M., Witkowski, M., Friebel, J., Buffa, J. A., Li, X. S., Wang, Z., Sangwan, N., Li, L., DiDonato, J. A., Tizian, C., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab263 · Cited by 122
Self-citationGut Metabolite TMAO Induces Synaptic Plasticity Deficits by Promoting Endoplasmic Reticulum Stress
Govindarajulu, M., Pinky, P. D., Steinke, I., Bloemer, J., Ramesh, S., Kariharan, T., Rella, R. T., Bhattacharya, S., Dhanasekaran, M., Suppiramaniam, V., et al. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00138 · Cited by 113
Simó, C., & García‐Cañas, V. (2020) · Food & Function · doi:10.1039/d0fo01237h · Cited by 112
Gut Metabolite Trimethylamine-N-Oxide in Atherosclerosis: From Mechanism to Therapy
Wang, B., Qiu, J., Lian, J., Yang, X., & Zhou, J. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.723886 · Cited by 109
Mechanisms linking preterm birth to onset of cardiovascular disease later in adulthood
Bavineni, M., Wassenaar, T. M., Agnihotri, K., Ussery, D. W., Lüscher, T. F., & Mehta, J. L. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz025 · Cited by 109
Importance of gut microbiota metabolites in the development of cardiovascular diseases (CVD)
Hemmati, M., Kashanipoor, S., Mazaheri, P., Alibabaei, F., Babaeizad, A., Asli, S., Mohammadi, S., Gorgin, A. H., Ghods, K., Yousefi, B., et al. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121947 · Cited by 105
Mamic, P., Chaikijurajai, T., & Tang, W. H. W. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.12.001 · Cited by 100
Self-citationContribution of Trimethylamine N-Oxide (TMAO) to Chronic Inflammatory and Degenerative Diseases
Constantino-Jonapa, L. A., Espinoza-Palacios, Y., Escalona‐Montaño, A. R., Hernández-Ruiz, P., Amezcua-Guerra, L. M., Amedei, A., & Aguirre‐García, M. M. (2023) · Biomedicines · doi:10.3390/biomedicines11020431 · Cited by 99
How important are fatty acids in human health and can they be used in treating diseases?
Dicks, L. M. T. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2420765 · Cited by 99
Leustean, A. M., Ciocoiu, M., Sava, A. C., Costea, C. F., Floria, M., Tărniceriu, C. C., & Tănase, D. M. (2018) · Journal of Diabetes Research · doi:10.1155/2018/5205126 · Cited by 94
Tang, W. H. W., Li, X. S., Wu, Y., Wang, Z., Khaw, K., Wareham, N. J., Nieuwdorp, M., Boekholdt, S. M., & Hazen, S. L. (2021) · American Heart Journal · doi:10.1016/j.ahj.2021.01.020 · Cited by 92
Self-citationGut Microbiota and Atherosclerosis
Li, D. Y., & Tang, W. H. W. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0675-9 · Cited by 90
Self-citationPathak, P., Helsley, R. N., Brown, A. L., Buffa, J. A., Choucair, I., Nemet, I., Baleanu‐Gogonea, C., Gogonea, V., Wang, Z., Garcı́a-Garcı́a, J. C., et al. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00584.2019 · Cited by 89
Self-citationOktaviono, Y. H., Lamara, A. D., Saputra, P. B. T., Arnindita, J. N., Pasahari, D., Saputra, M. E., & Suasti, N. M. A. (2023) · Biomolecules and Biomedicine · doi:10.17305/bb.2023.8893 · Cited by 92
Panyod, S., Wu, W., Chen, P.-C., Chong, K.-V., Yang, Y.-T., Chuang, H.-L., Chen, C., Chen, R.-A., Liu, P., Chung, C., et al. (2022) · npj Biofilms and Microbiomes · doi:10.1038/s41522-022-00266-3 · Cited by 85
Circulating Metabolites Originating from Gut Microbiota Control Endothelial Cell Function
Amedei, A., & Morbidelli, L. (2019) · Molecules · doi:10.3390/molecules24213992 · Cited by 84
Wang, M., Wang, Z., Lee, Y., Lai, H. T. M., Otto, M. C. D. O., Lemaître, R. N., Fretts, A. M., Sotoodehnia, N., Budoff, M. J., DiDonato, J. A., et al. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.316533 · Cited by 85
Self-citationWang, M., Li, X. S., Wang, Z., Otto, M. C. D. O., Lemaître, R. N., Fretts, A. M., Sotoodehnia, N., Budoff, M. J., Nemet, I., DiDonato, J. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad089 · Cited by 84
Self-citationIntestinal microbial metabolites in human metabolism and type 2 diabetes
Herrema, H., & Niess, J. H. (2020) · Diabetologia · doi:10.1007/s00125-020-05268-4 · Cited by 83
Trimethylamine N -oxide: heart of the microbiota–CVD nexus?
Naghipour, S., Cox, A. J., Peart, J. N., Toit, E. F. D., & Headrick, J. P. (2020) · Nutrition Research Reviews · doi:10.1017/s0954422420000177 · Cited by 77
Schugar, R. C., Gliniak, C. M., Osborn, L. J., Massey, W. J., Sangwan, N., Horak, A. J., Banerjee, R., Orabi, D., Helsley, R. N., Brown, A. L., et al. (2022) · eLife · doi:10.7554/elife.63998 · Cited by 75
Self-citationDifferential effect of short-term popular diets on TMAO and other cardio-metabolic risk markers
Park, J. E., Miller, M. J., Rhyne, J., Wang, Z., & Hazen, S. L. (2019) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.02.003 · Cited by 76
Self-citationThe Role of CYP450 Drug Metabolism in Precision Cardio-Oncology
Fatunde, O. A., & Brown, S.-A. N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020604 · Cited by 72
Breast Cancer: Lifestyle, the Human Gut Microbiota/Microbiome, and Survivorship
Bodai, B. I., & Nakata, T. E. (2020) · The Permanente Journal · doi:10.7812/tpp/19.129 · Cited by 73
Association of TrimethylamineN-Oxide and Related Metabolites in Plasma and Incident Type 2 Diabetes
Lemaître, R. N., Jensen, P. N., Wang, Z., Fretts, A. M., McKnight, B., Nemet, I., Biggs, M. L., Sotoodehnia, N., Otto, M. C. D. O., Psaty, B. M., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.22844 · Cited by 71
Self-citationNew Insights Into the Comorbidity of Coronary Heart Disease and Depression
Wu, Y., Zhu, B., Chen, Z., Duan, J., Luo, A., Yang, L., & Yang, C. (2019) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2019.03.002 · Cited by 72
Shih, D. M., Zhu, W., Schugar, R. C., Meng, Y., Jia, X., Miikeda, A., Wang, Z., Zieger, M., Lee, R., Graham, M., et al. (2019) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.119.312592 · Cited by 67
Self-citationTousoulis, D., Guzik, T. J., Padró, T., Duncker, D. J., Luca, G. D., Eringa, E. C., Vavlukis, M., Antonopoulos, A. S., Katsimichas, T., Cenko, E., et al. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac057 · Cited by 67
Vegan nutrition: a preliminary guide for health professionals
Koeder, C., & Pérez-Cueto, F. J. A. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2107997 · Cited by 65
The dietary source of trimethylamine N-oxide and clinical outcomes: an unexpected liaison
Evans, M., Dai, L., Avesani, C. M., Kublickiene, K. R., & Stenvinkel, P. (2023) · Clinical Kidney Journal · doi:10.1093/ckj/sfad095 · Cited by 68
Polsinelli, V. B., Sinha, A., & Shah, S. J. (2017) · Current Heart Failure Reports · doi:10.1007/s11897-017-0370-8 · Cited by 64
Circulating trimethylamine N-oxide levels following fish or seafood consumption
Wang, Z., Tang, W. H. W., O’Connell, T. F., Garcia, E., Jeyarajah, E. J., Li, X. S., Jia, X., Weeks, T. L., & Hazen, S. L. (2022) · European Journal of Nutrition · doi:10.1007/s00394-022-02803-4 · Cited by 63
Self-citationGut microbiome and metabolites, the future direction of diagnosis and treatment of atherosclerosis?
Cao, H., Zhu, Y., Hu, G., Zhang, Q., & Zheng, L. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106586 · Cited by 64
Myocardial infarction and gut microbiota: An incidental connection
Vahed, S. Z., Barzegari, A., Tamayo, M. Z., Letourneur, D., & Pavon‐Djavid, G. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.11.008 · Cited by 65
Liu, C., Cheng, L., Ji, L., Li, F., Zhan, Y., Wu, B., Yang, K., Chen, P., Hua, F., Yuan, L., et al. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.03.012 · Cited by 62
Zhao, L., Xing, C., Sun, W., Hou, G., Yang, G., & Yuan, L. (2018) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-018-3691-8 · Cited by 62
The Gut Microbial Endocrine Organ in Type 2 Diabetes
Massey, W. J., & Brown, J. M. (2020) · Endocrinology · doi:10.1210/endocr/bqaa235 · Cited by 61
Relationship Between the Gut Microbiome and Systemic Chemotherapy
Ervin, S. M., Ramanan, S. V., & Bhatt, A. P. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06119-3 · Cited by 62
Gut Microbiota Modulation as a Novel Therapeutic Strategy in Cardiometabolic Diseases
Mutalub, Y. B., Abdulwahab, M., Mohammed, A., Yahkub, A. M., Al-Mhanna, S. B., Yusof, W., Tang, S. P., Rasool, A. H. G., & Mokhtar, S. S. (2022) · Foods · doi:10.3390/foods11172575 · Cited by 64
Trimethylamine N‐oxide as a risk marker for ischemic stroke in patients with atrial fibrillation
Liang, Z., Dong, Z., Guo, M., Shen, Z., Yin, D., Hu, S., & Hai, X. (2019) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22246 · Cited by 57
Helsley, R. N., Miyata, T., Kadam, A., Varadharajan, V., Sangwan, N., Huang, E., Banerjee, R., Brown, A. L., Fung, K. K., Massey, W. J., et al. (2022) · eLife · doi:10.7554/elife.76554 · Cited by 57
Self-citationGut microbiome and its meta-omics perspectives: profound implications for cardiovascular diseases
Xu, J., & Yang, Y. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1936379 · Cited by 61
Tan, C., Wang, H., Gao, X., Xu, R., Zeng, X., Cui, Z., Zhu, J., Wu, Q., Xia, G., Zhou, H., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00029 · Cited by 55
McGranaghan, P., Kirwan, J., García-Rivera, M. A., Pieske, B. M., Edelmann, F., Blaschke, F., Appunni, S., Saxena, A., Rubens, M., Veledar, E., et al. (2021) · Metabolites · doi:10.3390/metabo11090621 · Cited by 55
Voigt, R. M., Wang, Z., Brown, J. M., Engen, P. A., Naqib, A., Goetz, C. G., Hall, D. A., Metman, L. V., Shaikh, M., Forsyth, C. B., et al. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105780 · Cited by 51
Self-citationEffects of gut microbiota on neurodegenerative diseases
Khatoon, S., Kalam, N., Rashid, S., & Bano, G. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1145241 · Cited by 55
Gessner, A., di Giuseppe, R., Koch, M., Fromm, M. F., Lieb, W., & Maas, R. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2019-1146 · Cited by 51
Gut Microbiome-Based Management of Patients With Heart Failure
Mamic, P., Snyder, M. P., & Tang, W. H. W. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.02.045 · Cited by 51
Self-citationGut microbiota and their metabolites in cardiovascular disease
Jansen, V. L. B. I., Gerdes, V. E. A., Middeldorp, S., & van Mens, T. E. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101492 · Cited by 50
Gut microbiota: a promising target against cardiometabolic diseases
Warmbrunn, M. V., Herrema, H., Aron‐Wisnewsky, J., Soeters, M. R., van Raalte, D. H., & Nieuwdorp, M. (2020) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2020.1720511 · Cited by 49
Targeting the human microbiome and its metabolite TMAO in cardiovascular prevention and therapy
Dannenberg, L., Zikeli, D., Benkhoff, M., Ahlbrecht, S., Kelm, M., Levkau, B., & Polzin, A. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107584 · Cited by 47
Fraser, K., Roy, N. C., Goumidi, L., Verdu, A., Suchon, P., Valentim, F. L., Trégouët, D., Morange, P., & Martin, J. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.314480 · Cited by 47
Small Molecule Metabolites at the Host–Microbiota Interface
Bishai, J. D., & Palm, N. W. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100528 · Cited by 50
Stroke and Vascular Cognitive Impairment: The Role of Intestinal Microbiota Metabolite TMAO
Tu, R., & Xia, J. (2024) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230203140805 · Cited by 47
Li, D. Y., & Tang, W. H. W. (2018) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2018.01.008 · Cited by 48
Self-citationTherapeutic potential of natural products against atherosclerosis: Targeting on gut microbiota
Zhao, X., Oduro, P. K., Tong, W., Wang, Y., Gao, X., & Wang, Q. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105362 · Cited by 47
Lemos, B. S., Vera, I., Malysheva, O., Caudill, M. A., & Fernández, M. L. (2018) · Journal of the American College of Nutrition · doi:10.1080/07315724.2018.1466213 · Cited by 46
Gencer, B., Li, X. S., Gurmu, Y., Bonaca, M. P., Morrow, D. A., Cohen, M. C., Bhatt, D. L., Steg, P. G., Storey, R. F., Johanson, P., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015331 · Cited by 47
Self-citationAdvances in understanding the molecular mechanisms of venous thrombosis
Preston, R. J. S., O’Sullivan, J. M., & O’Donnell, J. S. (2019) · British Journal of Haematology · doi:10.1111/bjh.15869 · Cited by 45
Brain–heart communication in health and diseases
Liu, W., Zhang, X., Wu, Z., Huang, K., Yang, C., & Yang, L. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.02.012 · Cited by 49
Vallance, H. D., Koochin, A., Branov, J., Rosen-Heath, A., Bosdet, T., Wang, Z., Hazen, S. L., & Horvath, G. A. (2018) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2018.04.005 · Cited by 46
Self-citation
Metadata
- Authors
- Zhu, W., Wang, Z., Tang, W. H. W., & Hazen, S. L.
- Affiliations
- Cleveland Clinic (US)
- Venue
- Circulation
- Published
- 2017-04-25
- Volume
- 135
- Issue
- 17
- Pages
- 1671-1673
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- PMC
- PMC5460631
- OpenAlex
- W2609064408
- Cited by
- 274
- References
- 5
- Citations by year
- 2026: 22 · 2025: 31 · 2024: 19 · 2023: 30 · 2022: 41 · 2021: 27 · 2020: 41 · 2019: 23 · 2018: 31 · 2017: 8
- FWCI
- 11.51
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL126827, R01HL103866)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK106000)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Polyamine Metabolism and Applications
- Keywords
- trimethylamine N-oxide, choline, gut microbiota, prothrombotic effects, thrombosis
- MeSH terms
- Vegans, Gastrointestinal Microbiome, Adult, Aspirin, Choline, Dietary Fats, Female, Humans, Male, Methylamines, Middle Aged, Thrombosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
